Page last updated: 2024-08-21

2-piperidone and Neointima

2-piperidone has been researched along with Neointima in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SH; Lee, IK; Leem, J; Oh, CJ; Park, KG; Park, S1

Other Studies

1 other study(ies) available for 2-piperidone and Neointima

ArticleYear
Dipeptidyl peptidase-4 inhibition by gemigliptin prevents abnormal vascular remodeling via NF-E2-related factor 2 activation.
    Vascular pharmacology, 2015, Volume: 73

    Topics: Animals; Carotid Artery Injuries; Cell Adhesion Molecules; Cell Movement; Cell Proliferation; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; G1 Phase Cell Cycle Checkpoints; HEK293 Cells; Humans; Hyperplasia; Male; Matrix Metalloproteinase 2; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; NF-E2-Related Factor 2; Piperidones; Pyrimidines; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Time Factors; Transfection; Vascular Remodeling

2015